-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Dianthus Therapeutics, Inc. /DE/ quarterly/annual Depreciation history and growth rate from Q3 2022 to Q2 2024.
- Dianthus Therapeutics, Inc. /DE/ Depreciation for the quarter ending June 30, 2024 was $23K, a 53.3% increase year-over-year.
- Dianthus Therapeutics, Inc. /DE/ Depreciation for the twelve months ending June 30, 2024 was $83K.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2023 was $67K, a 123% increase from 2022.
- Dianthus Therapeutics, Inc. /DE/ annual Depreciation for 2022 was $30K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)